• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症患者血清对自然杀伤细胞活性的抑制作用。

Suppression of natural killer cell activity by serum derived from head and neck cancer patients.

作者信息

Kumazawa H, Minamino M, Yukawa N, Hess M

机构信息

Department of Otorhinolaryngology, Kansai Medical University, Osaka, Japan.

出版信息

Cancer Detect Prev. 1995;19(6):494-502.

PMID:8925518
Abstract

Natural killer (NK) cells play an important role in many immune functions, including the lysis of tumor cells. In this study, we analyzed the influence of serum from 40 patients with head and neck cancer on NK cell activity using a double-layer agar assay. NK cell activity can be express as the inhibitory effect of NK cells on colony growth of K562 cells in the double-layer agar assay. When serum from cancer patients was added in this assay, we observed the reduction of the inhibitory activity of NK cells, not only of autologous NK cells but also of allogeneic NK cells in 24 out of 40 patients. In addition, we compared the TNM staging and survival rate between the reduction group and no-reduction group of NK cell activity. These results suggest that the serum of some patients with head and neck cancer may be an inhibitory factor on NK cell activity and may be involved in host resistance to tumor growth.

摘要

自然杀伤(NK)细胞在包括肿瘤细胞裂解在内的许多免疫功能中发挥着重要作用。在本研究中,我们使用双层琼脂试验分析了40例头颈癌患者的血清对NK细胞活性的影响。在双层琼脂试验中,NK细胞活性可以表示为NK细胞对K562细胞集落生长的抑制作用。当在该试验中加入癌症患者的血清时,我们观察到40例患者中有24例的NK细胞抑制活性降低,不仅自体NK细胞,异体NK细胞也是如此。此外,我们比较了NK细胞活性降低组和未降低组之间的TNM分期和生存率。这些结果表明,一些头颈癌患者的血清可能是NK细胞活性的抑制因子,可能参与宿主对肿瘤生长的抵抗。

相似文献

1
Suppression of natural killer cell activity by serum derived from head and neck cancer patients.头颈部癌症患者血清对自然杀伤细胞活性的抑制作用。
Cancer Detect Prev. 1995;19(6):494-502.
2
Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.肿瘤引流淋巴结中的自然杀伤细胞活性:对恶性黑色素瘤和头颈癌患者的研究
Nat Immun Cell Growth Regul. 1985;4(6):315-27.
3
Head and neck cancer triggers the internalization of TLR3 in natural killer cells.头颈癌会引发自然杀伤细胞中Toll样受体3(TLR3)的内化。
Int J Mol Med. 2007 Oct;20(4):493-9.
4
Influence of serum derived from patients with head and neck cancer on natural killer cell activity.头颈部癌症患者血清对自然杀伤细胞活性的影响。
Oncology. 1991;48(5):372-6. doi: 10.1159/000226962.
5
Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.响应单链免疫刺激RNA(ss-isRNA)时,自然杀伤(NK)细胞针对头颈癌的功能上调需要Toll样受体7(TLR7)。
Int J Oncol. 2008 Nov;33(5):993-1000.
6
Expansion of natural killer cells in patients with head and neck cancer: detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells.头颈部癌患者中自然杀伤细胞的扩增:循环自然杀伤细胞上“非抑制性”(激活型)杀伤性免疫球蛋白样受体的检测
Head Neck. 2003 Apr;25(4):297-305. doi: 10.1002/hed.10198.
7
Natural killer cell activity and head and neck cancer: a clinical assessment.自然杀伤细胞活性与头颈癌:一项临床评估。
J Natl Cancer Inst. 1986 Oct;77(4):869-75.
8
Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.头颈部癌症患者外周血、颈部淋巴结及肿瘤中的自然杀伤细胞细胞毒性。
Cancer Res. 1988 Sep 1;48(17):5017-22.
9
Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.胃癌患者可溶性细胞间黏附分子-1与自然杀伤细胞活性
Res Commun Mol Pathol Pharmacol. 1998 Jun;100(3):283-300.
10
Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.癌症患者血清对自然杀伤细胞活性的调节作用:一项关于结直肠癌或其他类型癌症患者的研究初步结果
Cancer Res. 1988 May 1;48(9):2596-603.

引用本文的文献

1
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.重新审视免疫监视与免疫刺激:对癌症免疫治疗的启示。
J Transl Med. 2005 Feb 8;3(1):8. doi: 10.1186/1479-5876-3-8.